Talphera (TLPH) Accumulated Expenses (2010 - 2026)
Talphera (TLPH) posted Accumulated Expenses of $3.2 million for Q2 2026, up 28.72% on a QoQ basis from $2.4 million in Q1 2026, and up 175.2% year-over-year from $1.1 million in Q2 2025.
Analysis
Talphera (TLPH) Accumulated Expenses (2010 - 2026) Analysis & Trends
Talphera has reported Accumulated Expenses for 17 years, with the latest figure at $3.2 million in Q2 2026.
- On a quarterly basis, Accumulated Expenses rose 175.2% year-over-year to $3.2 million in Q2 2026; TTM through Jun 2026 was $3.2 million, a 175.2% increase from a year earlier, with the FY2025 full-year figure at $2.6 million, up 108.53% from the prior year.
- Accumulated Expenses was $3.2 million for Q2 2026 at Talphera, up from $2.4 million in the prior quarter.
- The five-year high for Accumulated Expenses was $4.4 million in Q3 2022, with the low at $1.0 million in Q1 2025.
- Average Accumulated Expenses over 5 years is $2.3 million, with a median of $1.9 million recorded in 2023.
- The sharpest annual moves came in 2023 and 2026: Accumulated Expenses plunged 67.18% in 2023, then soared 175.2% in 2026.
- Over 5 years, Accumulated Expenses stood at $2.5 million in 2022, then dropped by 3.4% to $2.4 million in 2023, then tumbled by 48.71% to $1.3 million in 2024, then surged by 108.53% to $2.6 million in 2025, then climbed by 20.5% to $3.2 million in 2026.
- The last three Accumulated Expenses figures came in at $3.2 million (Q2 2026), $2.4 million (Q1 2026), and $2.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Talphera | 92.90 Mn | 92.90 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.15 Mn |
| Mar 31, 2026 | 2.45 Mn |
| Dec 31, 2025 | 2.62 Mn |
| Sep 30, 2025 | 2.04 Mn |
| Jun 30, 2025 | 1.15 Mn |
| Mar 31, 2025 | 1.01 Mn |
| Dec 31, 2024 | 1.25 Mn |
| Sep 30, 2024 | 1.64 Mn |
| Jun 30, 2024 | 1.74 Mn |
| Mar 31, 2024 | 1.34 Mn |
| Dec 31, 2023 | 2.45 Mn |
| Sep 30, 2023 | 1.79 Mn |
| Jun 30, 2023 | 1.85 Mn |
| Mar 31, 2023 | 1.42 Mn |
| Dec 31, 2022 | 2.53 Mn |
| Sep 30, 2022 | 4.40 Mn |
| Jun 30, 2022 | 4.26 Mn |
| Mar 31, 2022 | 4.32 Mn |
| Dec 31, 2021 | 6.52 Mn |
| Sep 30, 2021 | 5.33 Mn |